Enhörning et al. analyzed the association of increasing copeptin levels with the risk of new-onset type 2 diabetes (T2D) development in a Swedish population-based sample of 4742 subjects and found that elevated copeptin levels predicted diabetes independently of various diabetes risk factors, including fasting glucose and insulin levels [25]. The gene discussed is AVP; the disease is diabetes mellitus.